MHRA Drug Safety Update September 2019

MHRA Drug Safety Update September 2019

September 19, 2019

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 13 Issue 1 August 2019) has been published and includes articles on:

  • Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping
  • Fingolimod (Gilenya▼): increased risk of congenital malformations; new contraindication during pregnancy and in women of childbearing potential not using effective contraception
  • Elmiron (pentosan polysulfate sodium): rare risk of pigmentary maculopathy
  • Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions
  • Letters and drug alerts sent to healthcare professionals in August 2019
  • Medical Device Alerts issued in August 2019

To see the latest MHRA Drug Safety Update in full, visit the GOV.uk website.



Posted in:


More Latest News >

Self Care Week 2019

Self Care Week, which is an annual national awareness week that focuses on providing support for self care across communities and families,...

Final CPCS service spec published

Following its passage through the NHS England and NHS Improvement (NHSE&I) internal governance process, the final version of the Community...

Ask PSNC: Flu FAQs

The services team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2019/20. Below are...

PQS: NHSmail FAQs

The general NHSmail national helpdesk at NHS Digital has been receiving a number of queries from community pharmacy contractors about...